Evidence map›Paper›PMID 30160510›Full record

Trial reportPsychiatric rehabilitation journal2018

Race analysis in an African American sample with serious mental illness and comorbid diabetes.

Martha Sajatovic, Molly Howland, Douglas Gunzler, Stephanie W Kanuch, Kristin A Cassidy, Richard McCormick, Mark S Bauer, Thomas Scheidemantel, Charles Thomas, Carol Blixen and 1 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Psychiatric rehabilitation journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Martha SajatovicNeurological and Behavioral Outcomes Center, Case Western Reserve University School of Medicine.
Molly HowlandNeurological and Behavioral Outcomes Center, Case Western Reserve University School of Medicine.
Douglas GunzlerCenter for Health Care Research and Policy, Case Western Reserve University School of Medicine.
Stephanie W KanuchMetroHealth Medical Cente.
Kristin A CassidyUniversity Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine.
Richard McCormickCenter for Health Care Research and Policy, Case Western Reserve University.
Mark S BauerDepartment of Psychiatry, Harvard Medical School.
Thomas ScheidemantelScheidemantel, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine.
Charles ThomasMetroHealth Medical Center.
Carol BlixenNeurological and Behavioral Outcomes Center, Case Western Reserve University.
Neal V DawsonCenter for Health Care Research and Policy, Case Western Reserve University School of Medicine.

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
Improving Outcomes for Individuals with Serious Mental Illness and DiabetesR01MH085665 · NIMH · CASE WESTERN RESERVE UNIVERSITY · PI DAWSON, NEAL V, SAJATOVIC, MARTHA X · 2011 to 2015
$2.9M
National Institute of Mental Health; National Institutes of HealthNCATS NIH HHS KL2 TR000440NCATS NIH HHS UL1 TR000439NCRR NIH HHS UL1 RR024989NIH HHSNIMH NIH HHS R01 MH085665
6 · The paper itself

Abstract

objectivesTargeted Training in Illness Management (TTIM) focuses on enhancing care engagement for people living with serious mental illness and diabetes. This secondary analysis from a 60-week, randomized controlled trial of TTIM versus treatment as usual evaluated racial subgroup outcomes.

methodDemographics, clinical characteristics, and diabetes status were evaluated for those self-identifying as non-Hispanic White, African American, and Hispanic. Longitudinal response to TTIM was evaluated using a multiple domain risk index. Due to their small sample size; those identifying as Hispanic were excluded from this analysis.

resultsNon-Hispanic White participants had greater baseline socioeconomic advantages. Baseline risk scores, glycosylated hemoglobin (HbA1c) values, and HbA1c differences over time were similar for African American and non-Hispanic White participants. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: African American participants living with serious mental illness and diabetes receiving TTIM did as well as non-Hispanic White participants. Inclusive approaches that feature peer support and are situated in safety-net health care settings need to be further investigated with respect to potentially impacting health disparities. (PsycINFO Database Record

Indexed as

Black or African AmericanDiabetes MellitusMental DisordersOutcome Assessment, Health CareAdultComorbidityFemaleFollow-Up StudiesGlycated HemoglobinHumansMaleMiddle AgedPatient Education as TopicPsychotherapySelf-ManagementWhite PeopleGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID30160510
PMCPMC6442459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.